Jenna Philpott

Meningitis C cases are down 99% since the NHS routine vaccination programme was introduced by UKHSA and NHS England in 1999.

The government said that men are less likely than women to seek medical help, particularly for mental health issues.

The EMA's CHMP has endorsed expanding the use of Palforzia to toddlers aged one to three years with peanut allergies.

The MHRA has also granted approval to Faron Pharmaceuticals to conduct the BEXMAB trial of Clevegen in the UK.

Olema Oncology plans to start a Phase III trial studying palazestrant with a CDK4/6 inhibitor from Novartis in mid-2025.

Vertex has won two cystic fibrosis approvals from the FDA, but the agency included high-level safety warnings.

Lilly's Zepbound has become the first prescription medicine approved to treat adults with moderate to severe obstructive sleep apnoea (OSA) and obesity.

The FDA initially rejected the marketing application for Alhemo in 2022, asking for additional data on dosing and monitoring.

This seed funding comes after GEMMABio secured $100m in October through a partnership with Brazilian supplier Fiocruz.

2 min read Eli Lilly's blockbuster obesity drug, Zepbound (tirzepatide), has secured a label expansion from the US Food and Drug